635 related articles for article (PubMed ID: 32051933)
1. Is tau in the absence of amyloid on the Alzheimer's continuum?: A study of discordant PET positivity.
Weigand AJ; Bangen KJ; Thomas KR; Delano-Wood L; Gilbert PE; Brickman AM; Bondi MW;
Brain Commun; 2020; 2(1):fcz046. PubMed ID: 32051933
[TBL] [Abstract][Full Text] [Related]
2. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.
Lowe VJ; Wiste HJ; Senjem ML; Weigand SD; Therneau TM; Boeve BF; Josephs KA; Fang P; Pandey MK; Murray ME; Kantarci K; Jones DT; Vemuri P; Graff-Radford J; Schwarz CG; Machulda MM; Mielke MM; Roberts RO; Knopman DS; Petersen RC; Jack CR
Brain; 2018 Jan; 141(1):271-287. PubMed ID: 29228201
[TBL] [Abstract][Full Text] [Related]
3. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
4. Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Rodriguez JL; Snellman A; Suárez-Calvet M; Zetterberg H; Blennow K; Schöll M;
Brain; 2021 Feb; 144(1):325-339. PubMed ID: 33257949
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive characterization of elevated tau PET signal in the absence of amyloid-beta.
Weigand AJ; Edwards LE; Thomas KR; Bangen KJ; Bondi MW;
Brain Commun; 2022; 4(6):fcac272. PubMed ID: 36382220
[TBL] [Abstract][Full Text] [Related]
6. β-Amyloid discordance of cerebrospinal fluid and positron emission tomography imaging shows distinct spatial tau patterns.
Jiang C; Wang Q; Xie S; Chen Z; Fu L; Peng Q; Liang Y; Guo H; Guo T;
Brain Commun; 2022; 4(2):fcac084. PubMed ID: 35441134
[TBL] [Abstract][Full Text] [Related]
7. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
[TBL] [Abstract][Full Text] [Related]
8. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
Pascoal TA; Therriault J; Benedet AL; Savard M; Lussier FZ; Chamoun M; Tissot C; Qureshi MNI; Kang MS; Mathotaarachchi S; Stevenson J; Hopewell R; Massarweh G; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2020 Sep; 143(9):2818-2830. PubMed ID: 32671408
[TBL] [Abstract][Full Text] [Related]
9. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW;
Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939
[TBL] [Abstract][Full Text] [Related]
10. Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals.
Groot C; Smith R; Stomrud E; Binette AP; Leuzy A; Wuestefeld A; Wisse LEM; Palmqvist S; Mattsson-Carlgren N; Janelidze S; Strandberg O; Ossenkoppele R; Hansson O
Brain; 2023 Apr; 146(4):1580-1591. PubMed ID: 36084009
[TBL] [Abstract][Full Text] [Related]
11. Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.
Jack CR; Wiste HJ; Weigand SD; Therneau TM; Knopman DS; Lowe V; Vemuri P; Mielke MM; Roberts RO; Machulda MM; Senjem ML; Gunter JL; Rocca WA; Petersen RC
Lancet Neurol; 2017 Jun; 16(6):435-444. PubMed ID: 28456479
[TBL] [Abstract][Full Text] [Related]
12. Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition.
Risacher SL; WuDunn D; Tallman EF; West JD; Gao S; Farlow MR; Brosch JR; Apostolova LG; Saykin AJ
Brain Commun; 2020; 2(1):fcaa019. PubMed ID: 32309804
[TBL] [Abstract][Full Text] [Related]
13. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
[TBL] [Abstract][Full Text] [Related]
14. Detection of β-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers.
Tosun D; Veitch D; Aisen P; Jack CR; Jagust WJ; Petersen RC; Saykin AJ; Bollinger J; Ovod V; Mawuenyega KG; Bateman RJ; Shaw LM; Trojanowski JQ; Blennow K; Zetterberg H; Weiner MW
Brain Commun; 2021; 3(2):fcab008. PubMed ID: 33842885
[No Abstract] [Full Text] [Related]
15. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
16. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA
Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046
[TBL] [Abstract][Full Text] [Related]
17. Tau accumulation and its spatial progression across the Alzheimer's disease spectrum.
St-Onge F; Chapleau M; Breitner JCS; Villeneuve S; Pichet Binette A
Brain Commun; 2024; 6(1):fcae031. PubMed ID: 38410618
[TBL] [Abstract][Full Text] [Related]
18. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
[TBL] [Abstract][Full Text] [Related]
19. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
[TBL] [Abstract][Full Text] [Related]
20. Interaction effect of Alzheimer's disease pathology and education, occupation, and socioeconomic status as a proxy for cognitive reserve on cognitive performance: in vivo positron emission tomography study.
Yasuno F; Minami H; Hattori H;
Psychogeriatrics; 2020 Sep; 20(5):585-593. PubMed ID: 32285577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
